News Center

Home page

Peak Report

News reports

Pro 2013-002 (Announcement of Jianfeng Group on the Issuance of Corporate Bonds)

Release time:

2020-08-05

Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2013-002

Zhejiang Jianfeng Group Co., Ltd.

Announcement on Issuing Corporate Bonds

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .

Important Note: The Company intends to issue corporate bonds with a total amount of not more than 0.6 billion yuan and a maturity of not more than 7 years. will be used to repay some of the company's debts and to supplement the company's working capital .

Resolutions of the 1. Board of Directors

On December 31, 2012, the company held the 8th meeting of the 8th Board of Directors of Zhejiang Jianfeng Group Co., Ltd. by means of communication. The company currently has nine directors, and nine directors participating in the voting , comply with the provisions of the "Company Law" and the "Articles of Association", and the resolutions made are legal and valid. The meeting considered and proposal on the issuance of corporate bonds. after voting on the proposal in items, passed . the result of voting was all 9 votes for , 0 votes against , 0 abstentions. The specific contents of the

2. plan

1 and the issuance scale

The total face value of the corporate bonds issued this time shall not exceed .3 billion yuan (including .5 billion yuan). The specific issuance scale shall be submitted to the shareholders' general meeting to authorize the board of directors to determine within the above-mentioned scope.

2 , Placing Arrangement to Original Shareholders of the Company

This public offering of corporate bonds can be placed to shareholders of the Company. The specific placing arrangement ( includes whether to place, placing proportion, etc. ) is submitted to the shareholders' general meeting to authorize the board of directors to determine according to the market conditions at the time of issuance and the specific matters of issuance, and disclose it in the bond prospectus.

3 , Bond Term

The term of the corporate bonds issued this time is not more than 7 years, which can be a single term variety or a mixed variety of maturities, the specific term composition of the corporate bonds issued and the issuance scale of each term variety shall be submitted to the general meeting of shareholders to authorize the board of directors to determine in accordance with relevant regulations and market conditions before issuance.

4 , Bond Interest Rate and Determination Method

The current bond is a fixed-rate bond. The coupon rate of the current bond will be determined by the issuer and the sponsor (lead underwriter) according to the results of the offline inquiry in accordance with the relevant provisions of the state and after being filed by the regulatory authorities. The coupon rate of the bond is simple interest on an annual basis, without compound interest.

5 , Issuance Method

After the issuance is approved, the corporate bonds can be issued at one time or in installments. The specific issuance method is submitted to the general meeting of shareholders to authorize the board of directors to determine according to market conditions and the company's capital needs.

6 , Issuing Object

This corporate bond is issued to all investors, and investors subscribe in cash.

7 , Guarantee Arrangement

Whether this bond issue adopts guarantee and the specific guarantee method authorizes the board of directors to determine according to relevant regulations and market conditions.

8 , Use of Raised Funds

The raised funds of this issuance of corporate bonds are intended to be used to repay part of the company's debts , to supplement the company's working capital, optimize the company's debt structure , improve the company's capital situation. The general meeting of shareholders of the company is requested to authorize the board of directors to decide on the amount and proportion of the raised funds to repay the company's debts and supplement the working capital according to the actual situation of the company's financial situation.

9 , issuance of bonds listed

on the premise of meeting the listing conditions, the company will submit an application for listing and trading of this corporate bond to the Shanghai Stock Exchange as soon as possible after the issuance of this corporate bond.

10 , the validity period of the resolution

The validity period of the resolution on the issuance of corporate bonds is 24 months from the date of approval at this shareholders' meeting.

3. The above proposals still need to be submitted to the general meeting of shareholders for deliberation and submitted to the China Securities Regulatory Commission for approval before implementation .

hereby announce

Zhejiang Jianfeng Group Co., Ltd. Board of Directors

December 31, 2012

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页